Gyroscope Capital Management Group LLC grew its holdings in Metlife Inc (NYSE:MET) by 14.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 116,392 shares of the financial services provider’s stock after buying an additional 14,457 shares during the quarter. Metlife accounts for approximately 3.1% of Gyroscope Capital Management Group LLC’s holdings, making the stock its 6th biggest holding. Gyroscope Capital Management Group LLC’s holdings in Metlife were worth $6,047,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in MET. Prudential Financial Inc. increased its position in shares of Metlife by 71.4% during the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock worth $201,778,000 after purchasing an additional 1,529,570 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of Metlife by 5.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock worth $195,348,000 after purchasing an additional 175,311 shares in the last quarter. PGGM Investments increased its position in shares of Metlife by 2.3% during the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after purchasing an additional 12,978 shares in the last quarter. KBC Group NV increased its position in shares of Metlife by 14.3% during the 2nd quarter. KBC Group NV now owns 1,263,802 shares of the financial services provider’s stock worth $69,433,000 after purchasing an additional 157,734 shares in the last quarter. Finally, Rockefeller Financial Services Inc. increased its position in shares of Metlife by 189.7% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock worth $1,930,000 after purchasing an additional 24,330 shares in the last quarter. Institutional investors own 76.37% of the company’s stock.

In related news, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of Metlife stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

A number of equities research analysts recently issued reports on MET shares. Royal Bank of Canada reiterated a “buy” rating and set a $56.00 target price on shares of Metlife in a research report on Wednesday, September 6th. UBS reiterated a “neutral” rating and set a $49.00 target price (down previously from $57.00) on shares of Metlife in a research report on Friday, September 1st. ValuEngine cut shares of Metlife from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 26th. Zacks Investment Research upgraded shares of Metlife from a “hold” rating to a “buy” rating and set a $60.00 target price for the company in a research report on Thursday, November 9th. Finally, Sandler O’Neill cut shares of Metlife from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Metlife currently has a consensus rating of “Buy” and an average price target of $58.40.

Shares of Metlife Inc (NYSE MET) traded down $0.83 during midday trading on Thursday, hitting $52.84. 4,944,300 shares of the stock traded hands, compared to its average volume of 5,695,416. The company has a market cap of $56,476.88, a price-to-earnings ratio of 10.32, a PEG ratio of 1.35 and a beta of 1.49. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife Inc has a one year low of $44.26 and a one year high of $55.91.

Metlife (NYSE:MET) last issued its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.28 EPS. equities research analysts expect that Metlife Inc will post 4.43 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 13th. Investors of record on Monday, November 6th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.03%. The ex-dividend date of this dividend was Friday, November 3rd. Metlife’s payout ratio is -320.00%.

ILLEGAL ACTIVITY NOTICE: “Gyroscope Capital Management Group LLC Has $6.05 Million Stake in Metlife Inc (MET)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/14/gyroscope-capital-management-group-llc-has-6-05-million-stake-in-metlife-inc-met.html.

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Stock Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related stocks with our FREE daily email newsletter.